Hypoxia enhances the expression of plasminogen activator inhibitor-1 in human lung cancer cells, EBC-1

Tohoku J Exp Med. 2002 Apr;196(4):259-67. doi: 10.1620/tjem.196.259.

Abstract

Plasminogen activator inhibitor-1 (PAI-1) is one of the target genes of hypoxia inducible factor-1alpha (HIF-1alpha). Besides being an important physiological regulator of the fibrinolytic system PAI-1 is also involved in cancer invasiveness. HIF-1alpha is expressed in various types of pulmonary cells, but the relation of PAI-1 to HIF-1alpha under hypoxic condition in these cells are not fully elucidated. We, therefore, studied the effect of hypoxia on the expression of PAI-1 in a lung cancer cell line EBC-1. The expression of HIF-1alpha protein in EBC-1 cells was enhanced by hypoxia, and this was associated with increased secretion of PAI-1. Hypoxia did not affect the levels of HIF-1alpha mRNA but enhanced the PAI-1 mRNA. Pretreatment of the cells with MG132, which inhibits the proteasomal degradation of HIF-1alpha, increased the production of PAI-1 under both normoxia and hypoxia. We conclude that hypoxia induces PAI-1 expression, in EBC-1 cells, through the stabilization of HIF-1 complex and this may be related to cancer metastasis.

MeSH terms

  • Cell Hypoxia
  • Cysteine Proteinase Inhibitors / pharmacology
  • Dactinomycin / pharmacology
  • Gene Expression* / drug effects
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Immunohistochemistry
  • Leupeptins / pharmacology
  • Lung Neoplasms
  • Neoplasms, Squamous Cell
  • Plasminogen Activator Inhibitor 1 / biosynthesis
  • Plasminogen Activator Inhibitor 1 / genetics*
  • Transcription Factors / biosynthesis
  • Transcription Factors / genetics
  • Tumor Cells, Cultured

Substances

  • Cysteine Proteinase Inhibitors
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Leupeptins
  • Plasminogen Activator Inhibitor 1
  • Transcription Factors
  • Dactinomycin
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde